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Synopsis: Elevated vaginal pH in comparison shortened cervical length in mid trimester has better 
diagnostic accuracy regarding the prediction of early preterm labor in low-risk population 
 
 
 
 
 
Abstract 
 
Objective: To assess diagnostic accuracy of vaginal pH and cervical length (CL) measurement in 
mid trimester in order to predict preterm labor (PTL). 
Methods: Prospective cohort study of 316 low-risk pregnant women. Vaginal pH was measured 
using test gloves for measuring the vaginal acidity, while CL was measured using transvaginal 
ultrasound. The cut off value for vaginal pH used was 5.0 (95th centile for our population) whereas 
shortened CL was defined as < 26 mm (5th centile for our population).  
Results: Elevated vaginal pH was found in 4.4% whereas shortened CL was found in 2.8%. The 
incidence of PTL (< 37 weeks) was 7.2%, and early PTL (< 34 weeks) was 3.4%. Shortened CL is 
significantly related to PTL (LR weighted by prevalence 2.7, 95% CI 1.1–6.7) but is not to early PTL 
(LR weighted by prevalence 0.8, 95% CI 0.4–1.8). Elevated vaginal pH is better predictor of PTL 
(LR weighted by prevalence 3.7, 95% CI 1.3–10.4) and early PTL (LR weighted by prevalence 1.7, 
95% CI 1.1–3.1).  
Conclusion: Elevated vaginal pH has better accuracy in comparison with shortened CL regarding the 
prediction of early PTL in low risk pregnant women.  
Introduction 
 
Despite intensive research and numerous advances achieved in modern perinatal medicine, preterm 
labor (PTL) still remains the leading contributor to perinatal mortality and morbidity  1. In recent 
years there was increasing interest in two topics related to screening for PTL; bacterial vaginosis 
(BV) and cervical insufficiency. Both of them can be diagnosed using simple, safe, well accepted, 
reliable and reproducible methods; and they are potentially treatable 1-3. 
Bacterial vaginosis is commonest lower genital tract infection in women of reproductive age 4. By 
definition, it is an imbalance of the vaginal ecosystem caused by overgrowing the normal lactobacilli 
flora by Gardnerella vaginalis, Ureaplasma urealyticum, Mycoplasma hominis, Mobiluncus species, 
Prevotella species and other anaerobes 5-6. It is usually asymptomatic disease but associated with 
increased rate of PTL and unfavorable fetal outcome 1,2,5,7-12. However, despite that BV is potentially 
treatable, recent meta-analysis shows conflicting data about the benefits and risks of routine screening 
for BV, especially in the low risk population 3,5,13. 
Similar things may apply for cervical insufficiency and its relation to PTL. It is also asymptomatic 
condition, it is approachable by simple diagnostic methods and potentially treatable 1,2,14-17. 
Numerous investigators reported the relationship and usefulness of transvaginal ultrasound 
assessment of the uterine cervical length (CL) in mid trimester regarding the prediction of PTL in 
asymptomatic low-risk pregnancies.1,17-20.  
In order to assess diagnostic potential for PTL screening in low risk population, we performed 
prospective cohort study of cervical insufficiency assessment by ultrasound measurement of CL and 
detection of BV by measuring vaginal pH in mid trimester. 
Materials and Methods 
This prospective cohort study was a part of a research project designed to assess the efficacy of 
different diagnostic methods as a potential screening tests for PTL (Croatian Ministry of Science, 
Education and Sport, Project No 108-0000000-0378). 
At University Department of Obstetrics and Gynecology, Medical School, “Sveti Duh” Hospital, 
Zagreb, Croatia; pregnant women with uncomplicated singleton pregnancy between 18 and 24 weeks 
were approached and offered participation in the study. At that gestational age all women are booked 
for anomaly scan and therefore attending our hospital clinic eliminating the need for additional 
hospital visit. 
The exclusion criteria for enrollment were: 
1. Positive history of previous PTL, 
2. Pregnancy after method of assisted reproduction (IVF/ET), 
3. Clinically (palpable uterine contractions, abdominal pain, and temperature > 38.5 C) or laboratory 
(White cell count > 16 x 1012/l, C reactive protein > 10 mg/l) suspected chorioamnionitis before 
enrollment, 
4. Preterm prelabour rupture of the membranes or vaginal hemorrhage, 
5. History of surgical procedure on the cervix (i.e. knife cone biopsy etc.), 
6. Developmental malformations of Műllerian ducts found before pregnancy, 
7. Cervical cerclage before enrollment, 
8. The use of any local vaginal preparations that could influence on vaginal pH value in the last 24 
hours or sexual intercourse in the last 24 hours, 
9. Other medical conditions that are risk factors for preterm delivery (i.e. preeclampsia, auto immune 
diseases, diabetes etc.), 
10. Major congenital fetal anomalies or intrauterine fetal death. 
Gestational age was determined by comparing a last menstrual period (if available) with a corrections 
made on ultrasound measurements performed at first trimester scan. Because of conflicting results 
about potential benefits and/or harms of screening and treating asymptomatic women for BV and/or 
cervical insufficiency, the results obtained in the study were known to the principal investigators only 
(RM, OG and MK), and the course of the pregnancy was unaltered by the participation in the study. 
Local and national ethic committee approved the study protocol and all women included in the study 
gave their informed written consent. 
In order to assess BV the vaginal pH was measured using CarePlan VpH (Unipath Ltd, Bedford, 
MK33 3UP, UK) test gloves for measuring the vaginal acidity. The glove was used in the standard 
matter inserting the index finger with a test paper in posterior vaginal fornix. The lubricants were not 
used in order to avoid possible influence to the results. The vaginal 
pH 5.0 (> 95th centile) for our study population was defined as elevated and used as predictive 
parameter for BV. The same cut off value has been used in many other studies 11, 21-23.  
Ultrasound examination of the cervix was performed immediately after the measurement vaginal pH 
with a 7-MHz transducer (model 6117, Aloka 5500, ALOKA CO. LTD, Tokyo, Japan). Every 
cervical screening was performed according to the protocol described by Owen et al 14. The CL below 
the 5th centile was defined as shortened (< 26 mm) and suggestive of cervical insufficiency. This 
value is in concordance to the previously published results for our population ranging from 25 do 26 
mm 18-20,.   
Every pregnant woman was scanned only once for study purposes by one of the investigators. The 
cervical assessment was carried out over a period of 3 - 5 minutes in order to detect spontaneous 
dynamic cervical changes. At least three measurements were made and the lowest value was used for 
further calculations. 
 
As a part of the study design, a sample size calculation was performed (Sample size calculator, 
MaCorr Inc., Toronto, Ontario, Canada). The calculation was designed to detect at least 10 % 
difference between likelihood for prediction of early PTL < 34 weeks between shortened CL and high 
vaginal pH in low risk population. As a first step the confidence interval (CI) was determined using 
the confidence level of 95% in a sample population of 100 participants with at least 10% difference in 
likelihood for prediction of PTL between two parameters. The program has calculated that CI is 5.9 
%. As a second step using confidence level of 95% and CI of 5.9 % the program has calculated that 
for our population the sample size needs to be 276 subjects. 
Data were analyzed using SPSS version 16.0 (SPSS Inc., Chicago IL, USA). Vaginal pH value and 
CL were the variables used to predict outcomes. Centiles for the CL and vaginal pH were analyzed by 
the use of chi-square tests. For vaginal pH the cut off value > 95th centile (> 5.0) for our population 
was defined as elevated. Celvical length < 5th centile (< 26 mm) was defined as shortened.      
Outcome measures included sensitivity, specificity, positive predictive value (PPV) and negative 
predictive value (NPV) with 95% CI for shortened CL and elevated vaginal pH regarding the 
prediction of PTL < 37 weeks and early PTL < 34 weeks. 
Among various statistical measures that incorporate both sensitivity and specificity for description of 
validity of diagnostic or screening tests we opted for positive likelihood ratio (LR) and LR weighted 
by prevalence. Other classical statistical measures, including LR, are based exclusively on sensitivity 
and specificity and therefore they do not accept disease prevalence. In some circumstances, the 
accuracy weighted by prevalence gives different and better impression of the validity of a test 
especially in a population with a low prevalence for some outcomes.   
We calculated conventional LR and LR weighted by prevalence for positive results with 95 % CI 
comparing subjects with CL <5th centile with those > 5th centile, and subjects with vaginal pH > 95th 
centile with those < 95th centile.  
 
 
 
 
 
Results 
During the study period (March 2007 to September 2009) 343 women were approached fulfilling 
predefined entry criteria; 23 decided not to participate and 4 were lost from follow up (i.e. did not 
deliver in our hospital neither were available by the phone number or address given at enrolment). 
Therefore, our final analysis was based on 316 women. 
All of them had assessment of vaginal pH and transvaginal ultrasound examination of the cervix 
between 18 and 24 weeks gestation. Maternal age (median [interquartile range (IQR)]) at enrollment 
was 30 [27-35] years and median gestational age was 19 and IQR [18-22] weeks. Mean CL was 41 
mm with standard deviation of 8, and the median vaginal pH value was 4.4; IQR [4.0-4.7]. 
The incidence of PTL < 37 weeks in our group was 23/316 (7.2%) while the incidence of early PTL < 
34 weeks was 8/316 (2.5%). The shortened CL (< 26 mm being below 5th centile for our study 
population) was found in 15/316 (4.7%) women (ranged between 4 to 26 mm). Four of them 
delivered at term while other 11 delivered < 37 weeks. Among them 7 delivered < 34 weeks. Normal 
CL, i.e. above 5th centile for study population, was found in 301 (95.2%) women; 289 of them 
delivered at term while 12 delivered < 37 weeks and one delivered < 34 weeks. 
High vaginal pH of 5.0 and above that represents 95th centile for our study population was found in 
14/316 women (4.4%). In population with high vaginal pH, 3 women delivered at term, 11 delivered 
< 37 weeks and among them 7 delivered < 34 weeks. 
Diagnostic accuracy of CL and BV in relation to PTL and early PTL are presented in Table 1 and 2. 
Shortened CL is significantly related to PTL (LR 35.1, 95% CI 12.1 – 101.4). Vaginal pH > 5.0 had 
higher LR for prediction of PTL risk (LR 46.7, 95% CI 14.0 – 155.7). Similar observation is noted if 
LR weighted for prevalence is used. Regarding the risk assessment for early PTL, the results are in 
favor of vaginal pH above 5.0 (LR 38.5, 95% CI 17.7 – 83.8). If we take a prevalence of PTL into the 
calculation of LR, only pH > 5.0 had statistical significance regarding the prediction of PTL > 34 
weeks (LR 1.7, 95% CI 1.1 – 3.1).  
 
 
Discussion 
We found significant correlation between raised vaginal pH value and shortened ultrasound CL 
measurement regarding the prediction of PTL in low risk population. The distribution of CL values 
obtained in our study was similar to the previously published reports 14-18. Comparing the accuracy 
for prediction of early PTL, the 5th centile of CL (< 26 mm)  in our study and the 5th centile of CL (< 
22mm) in the study of Iams et al; our results showed better PPV (46.6% versus 26%) and better 
sensitivity (87.5% versus 30%) 15. It is our belief that such difference is results of relatively low 
number of women included in our study but it might be also influenced by the CL cut of point value 
used in order to diagnose cervical insufficiency. The results of diagnostic accuracy obtained in this 
study are even better compared to some our previously published reports 18, 19. We believe that this 
difference represents our personal learning curve improvement in CL assessment and screening for 
PTL. 
The accuracy of our results, regarding the prediction of PTL < 37 weeks is comparable with the 
results of Taipale and Hiilesmaa and the minor differences also can be explained by the relatively low 
number of women included 16. With significant difference found on conventional LR and LR 
weighted by prevalence calculation (35.1 and 2.7) we conclude that CL measurement has its place in 
the assessment of low risk pregnant women in population based PTL screening programs. This is 
already confirmed by some of our previously published reports 18, 19. Unfortunately, this significance 
is not so good in the assessment of low risk population for early PTL. Conventional LR is statistically 
significant being 33.7 (95% CI 16.2 – 70.1) but LR weighted by prevalence is not being 0.8 (95% CI 
0.4 – 1.8). 
Therefore, additional test would be very welcome and we expanded our cervical insufficiency 
screening program with screening for BV. Among the different diagnostic test for detection of BV we 
opted for vaginal pH measurement because its simplicity as well as correlation between increased pH 
value and BV 11,20-22. Some investigators pointed out that incresed vaginal pH > 5.0 is the strongest 
predictors among different clinical predictors regarding the detection of BV 11,21-23. Jazayeri et al. in 
their prospective study pointed out that pregnant women with elevated vaginal pH > 5.0 had 
significantly higher incidence of PTD < 37 weeks (OR 9.6, 95% CI 2.0 - 45.5) 21. Furthermore, 
Simhan et al. in series of 13917 pregnant women found vaginal pH > 5.0 in second trimester strongly 
associated with PTD < 32 weeks (OR 1.7 [1.1-2.6]) 11. The results od Cauci et al. suggest that 
combinations of vaginal biomarkers (vaginal pH > 5.0, incresed sialidase and prolidase activities) are 
associated with clinically important risks of PTL if performed in the second trimester 22. Hauth et al. 
pointed out that only vaginal pH > 5.0 in early pregnancy is significantly connected with higher 
incidence of PTL in comparison with pH < 5.0 23. 
Leitich and Kiss recently updated a previously published meta-analysis where they evaluated BV and 
intermediate vaginal flora as risk factors for adverse pregnancy outcome 3,24. Totaly, 32 studies with 
30,518 patients were assessed. Outcomes were preterm delivery, late miscarriage, maternal or 
neonatal infection and perinatal mortality. They found that BV more than doubles the risk of preterm 
delivery in asymptomatic pregnant women (OR 2.16, 95% CI 1.56-3.00) as well as in pregnant 
women with symptoms of preterm labor (OR 2.38, 95% CI 1.02-5.58) 24.  
When vaginal pH value of 5.0 and more (representing 95th centile for our population) is used in order 
to define BV, the number of screening positive women was 4.4% (14/316), LR weighted by 
prevalence for PTL was 3.7 (95% CI 1.3 – 10.4) and 1.7 for early PTL (95% CI 1.1 – 3.1). This pH 
cut of point is significant and may be relevant for screening purposes in low risk population 
especially for prediction of early PTL. Regarding that matter, our results are similar compared to 
other authors pointing vaginal pH as one of the most predictive parameter for prediction of PTL but 
only using a cut off pH value of 5.0 and more 21-24.  
Based on our results it can be concluded that both, CL measurements and vaginal pH assessment, 
representing screening tests for cervical insufficiency and BV are highly specific and accurate in the 
screening for PTL in low risk population. However, high vaginal pH assessment has better diagnostic 
accuracy in prediction and determination of the risk for early PTL < 34 weeks.  
As recently publshed, interventions to reduce the morbidity and mortality related to PTL can be either 
primary (directed to all women), secondary (aimed at eliminating or reducing existing risk), or 
tertiary (intended to improve outcomes for preterm infants) 25. In this aspect, regionalized care, 
corticosteroids, tocolytic agents and antibiotics have reduced perinatal morbidity and mortality; but 
the incidence of PTL is still increased 25. Therefore, advances in primary and secondary care are 
needed and may be useful for the benefits of the both, mother and their infants. We strongly believe 
that, screening programs designed to define population at risk for PTL may come closely to that goal. 
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